These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35412907)

  • 1. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
    Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
    Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
    Agrawal T; Maddileti S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RB1: a prototype tumor suppressor and an enigma.
    Dyson NJ
    Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?
    Imbert-Bouteille M; Gauthier-Villars M; Leroux D; Meunier I; Aerts I; Lumbroso-Le Rouic L; Lejeune S; Delnatte C; Abadie C; Pujol P; Houdayer C; Corsini C
    Mol Genet Genomic Med; 2019 Dec; 7(12):e913. PubMed ID: 31568710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
    Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
    Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
    Vincent A; Krishnakumar S; Parameswaran S
    Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in retinoblastoma genome stability is driven by age and not heritability.
    Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
    Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
    Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
    Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
    Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Ahmed RM; Denman M; Steele CD; Tarabichi M; Roy E; Davies LR; Manji J; Cristalli C; Scotlandi K; Pillay N; Strauss SJ; Mittnacht S
    Nat Commun; 2021 Dec; 12(1):7064. PubMed ID: 34862364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel germline mutation in the RB1 gene with multifocal bone tumors following retinoblastoma.
    Matsumoto H; Kobayashi O; Tamura K; Sekine I; Yamamoto M
    Pediatr Int; 2003 Dec; 45(6):728-30. PubMed ID: 14651550
    [No Abstract]   [Full Text] [Related]  

  • 19. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.